Skip to main content

Aeglea BioTherapeutics, Inc. - Common Stock (NQ: AGLE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist

Insider Filings

Form 3
Source: SEC/Edgar
March 07, 2019
Form 4
Source: SEC/Edgar
March 07, 2019
Form 4
Source: SEC/Edgar
February 28, 2019
Form 4
Source: SEC/Edgar
February 28, 2019
Form 4
Source: SEC/Edgar
February 28, 2019
Form 4
Source: SEC/Edgar
February 28, 2019
Form 4
Source: SEC/Edgar
February 07, 2019
Form 4
Source: SEC/Edgar
December 09, 2018
Form 4
Source: SEC/Edgar
September 27, 2018
Form 4
Source: SEC/Edgar
August 20, 2018
Form 4
Source: SEC/Edgar
August 14, 2018
Form 4
Source: SEC/Edgar
July 19, 2018
Form 3
Source: SEC/Edgar
July 16, 2018
Form 4
Source: SEC/Edgar
July 16, 2018
Form 4
Source: SEC/Edgar
July 15, 2018
Form 4
Source: SEC/Edgar
July 12, 2018
Form 4
Source: SEC/Edgar
June 07, 2018
Form 4
Source: SEC/Edgar
June 07, 2018
Form 4
Source: SEC/Edgar
June 07, 2018
Form 4
Source: SEC/Edgar
June 07, 2018
Form 4
Source: SEC/Edgar
June 07, 2018
Form 4
Source: SEC/Edgar
May 13, 2018
Form 4
Source: SEC/Edgar
May 10, 2018
Form 4
Source: SEC/Edgar
May 08, 2018
Form 4
Source: SEC/Edgar
February 19, 2018
Form 4
Source: SEC/Edgar
December 07, 2017
Form 4
Source: SEC/Edgar
December 04, 2017
Form 4
Source: SEC/Edgar
December 04, 2017
Form 4
Source: SEC/Edgar
December 04, 2017
Form 4
Source: SEC/Edgar
December 04, 2017
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.